These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32297302)

  • 1. Estrogen Signaling in Alzheimer's Disease: Molecular Insights and Therapeutic Targets for Alzheimer's Dementia.
    Uddin MS; Rahman MM; Jakaria M; Rahman MS; Hossain MS; Islam A; Ahmed M; Mathew B; Omar UM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2020 Jun; 57(6):2654-2670. PubMed ID: 32297302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic hormones receptors in Alzheimer's disease.
    Tecalco-Cruz AC; Zepeda-Cervantes J; Ortega-Domínguez B
    Mol Biol Rep; 2021 Nov; 48(11):7517-7526. PubMed ID: 34657250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer's disease.
    Ishunina TA; Kamphorst W; Swaab DF
    Neurobiol Aging; 2003 Oct; 24(6):817-28. PubMed ID: 12927764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.
    Sato K; Takayama KI; Inoue S
    Front Endocrinol (Lausanne); 2023; 14():1220150. PubMed ID: 37469978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer's disease in aging women.
    Tecalco-Cruz AC; López-Canovas L; Azuara-Liceaga E
    Metab Brain Dis; 2023 Mar; 38(3):783-793. PubMed ID: 36640216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease.
    Lan YL; Zhao J; Li S
    J Alzheimers Dis; 2015; 43(4):1137-48. PubMed ID: 25159676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen signalling and Alzheimer's disease: Decoding molecular mechanisms for therapeutic breakthrough.
    Rishabh ; Rohilla M; Bansal S; Bansal N; Chauhan S; Sharma S; Goyal N; Gupta S
    Eur J Neurosci; 2024 Jul; 60(1):3466-3490. PubMed ID: 38726764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging.
    Ishunina TA; Swaab DF
    Exp Neurol; 2003 Sep; 183(1):159-72. PubMed ID: 12957499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
    Correia SC; Santos RX; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Curr Aging Sci; 2010 Jul; 3(2):113-26. PubMed ID: 20167003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-Related Factors in the Frontal Lobe of Alzheimer's Disease Patients and Importance of Body Mass Index.
    Honma N; Saji S; Mikami T; Yoshimura N; Mori S; Saito Y; Murayama S; Harada N
    Sci Rep; 2017 Apr; 7(1):726. PubMed ID: 28389656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease.
    Lu YP; Zeng M; Swaab DF; Ravid R; Zhou JN
    Hum Pathol; 2004 Mar; 35(3):275-80. PubMed ID: 15017582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy.
    Cipriano GL; Mazzon E; Anchesi I
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease.
    Savaskan E; Olivieri G; Meier F; Ravid R; Müller-Spahn F
    Brain Res; 2001 Jul; 908(2):113-9. PubMed ID: 11454321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen: a master regulator of bioenergetic systems in the brain and body.
    Rettberg JR; Yao J; Brinton RD
    Front Neuroendocrinol; 2014 Jan; 35(1):8-30. PubMed ID: 23994581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and Alzheimer's disease: the story so far.
    Cholerton B; Gleason CE; Baker LD; Asthana S
    Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors and the aging brain.
    Maioli S; Leander K; Nilsson P; Nalvarte I
    Essays Biochem; 2021 Dec; 65(6):913-925. PubMed ID: 34623401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology.
    Hestiantoro A; Swaab DF
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1912-25. PubMed ID: 15070964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting estrogen receptors for the treatment of Alzheimer's disease.
    Lee JH; Jiang Y; Han DH; Shin SK; Choi WH; Lee MJ
    Mol Neurobiol; 2014 Feb; 49(1):39-49. PubMed ID: 23771838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.